Skip to content
Search

Latest Stories

Focus needs to be on pharmacy after GPs get additional funding boost

Focus on pharmacy after GPs get funding boost

GPs will now have funding to see more patients

Pic credit: iStock

An improved contract for community pharmacy should now be next on the government’s agenda after GPs were given an extra £889m in a contract agreed on Friday (28).

The new agreement for the 2025/26 financial year will see the total value of the GP contract grow by 7.2%.


Pharmacy has been without a contract since April 2024 and whilst negotiations between Community Pharmacy England (CPE) and the government remain ongoing, there is no fixed date as to when a new contract will be announced.

Malcolm Harrison, chief executive at The Company Chemists' Association (CCA), said: “We are pleased that the government’s actions reflect their stated ambition to move care from hospital to community. Now, it is time to focus on the community pharmacy contract.

“We are hopeful that this positive intent will also be reflected in the contract for pharmacies that is currently being negotiated. Core funding for community pharmacy has decreased in real-terms by over £1bn since 2015/16, and it is past time for pharmacies to see a funding increase.”

In the new contract agreed with the British Medical Council (BMA), to ensure the functionality in GP Connect is enabled by October.

The GP Connect Update Record will allow community pharmacies to securely share “structured” information with GP practices regarding consultations conducted under the Pharmacy First programme, which includes minor illness and clinical pathways, along with hypertension case finding and pharmacy contraception services.

As a result of collective action over a lack of funding, GPs stopped using the service last July.

“Enabling GP Connect will allow for more integration between GPs and community pharmacy. This is essential to providing patients with the best possible care and bringing together all parts of primary care,” said Harrison.

More For You

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
National Insurance Bill debated in the the House of Lords

National Insurance Bill debated in the the House of Lords

Lords back amendment to exempt pharmacies from national insurance hike

Pharmacies are expected to be exempted from national insurance contributions following an amendment to the National Insurance Contributions (Secondary Class 1 Contributions) Bill, which was approved by the House of Lords on Tuesday, 25 February 2025.

In the 2024 Autumn Budget, Chancellor Rachel Reeves announced an increase in the employer secondary Class 1 National Insurance contributions rate, rising from 13.8% to 15% starting in April 2025.

Keep ReadingShow less
Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less
GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less